Jury Rules Zantac Not Linked to Woman's Cancer in Landmark Trial
TL;DR Summary
A Chicago jury ruled that the heartburn drug Zantac did not cause an Illinois woman's colon cancer, marking the first trial among thousands of similar lawsuits. The jury sided with drugmakers GSK and Boehringer Ingelheim, who argued that there was no scientific evidence linking Zantac to cancer. The plaintiff, Angela Valadez, had sought $640 million in damages, but the jury found insufficient proof that Zantac was a cause of her cancer. The companies plan to continue defending against future claims.
- Zantac not a cause of woman's cancer, jury says in first trial over drug Reuters
- Whistleblower lawsuit claims GSK knew of Zantac risks for decades FiercePharma
- Zantac did not cause Brookfield woman's colon cancer, Cook County jury rules Chicago Sun-Times
- Common heartburn pill caused my colon cancer, claims Illinois woman, 89, in landmark lawsuit Daily Mail
- Zantac didn't cause 89-year-old woman's cancer, jury says in first trial over drug New York Post
Reading Insights
Total Reads
0
Unique Readers
2
Time Saved
3 min
vs 4 min read
Condensed
88%
680 → 80 words
Want the full story? Read the original article
Read on Reuters